Premium
Cervicovaginal HPV Infection in Female Renal Transplant Recipients: An Observational, Self‐Sampling Based, Cohort Study
Author(s) -
Meeuwis K. A. P.,
Hilbrands L. B.,
IntHout J.,
Slangen B. F. M.,
Hendriks I. M. P.,
Hinten F.,
Christiaans M. H. L.,
Quint W. G. V.,
van de Kerkhof P. C. M.,
Massuger L. F. A. G.,
Hoitsma A. J.,
van Rossum M. M.,
Melchers W. J. G.,
de Hullu J. A.
Publication year - 2015
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.13053
Subject(s) - medicine , cohort , population , hpv infection , genotyping , cohort study , occult , genotype , gynecology , pathology , cervical cancer , cancer , biochemistry , environmental health , gene , chemistry , alternative medicine
Immunosuppressive treatment of organ transplant recipients is associated with an increase in the occurrence of human papillomavirus (HPV) related anogenital (pre)malignancies. This cohort study investigated the genotype‐specific prevalence of HPV infections in a large cohort of female renal transplant recipients (RTRs). Participants self‐collected a cervicovaginal sample for detection and genotyping of HPV. Besides, they completed a questionnaire regarding sociodemographic variables, medical data and sexual behavior. Anogenital screening was offered to all HPV‐positive participants. A total number of 218 female RTRs was included. The prevalence of mucosal HPV infections was 27.1% and 17.4% for high risk HPV in particular. The studied cohort showed a broad range of HPV genotypes and multiple HPV genotypes were found in 27.1% of HPV‐positive patients. Seven participants were identified with occult premalignant anogenital lesions. In conclusion, this study shows a high point‐prevalence of HPV in female RTRs (age‐matched West‐European general population: 9–10%) with a shift in the distribution of genotypes as compared with the general population. Moreover, a substantial number of patients with occult premalignancies was identified. The introduction of self‐sampling for HPV positivity can help in early detection of (pre)malignant anogenital lesions in this vulnerable population.